Glucose-6-phosphate dehydrogenase deficiency (G6PDd) is a common genetic disorder affecting around 400 million people worldwide. Rapid diagnosis with FINDER G6PD test ensures timely intervention, improving patient outcomes and saving healthcare resources.
Any test. Anywhere. Everyone.™
FINDER® Near-Patient Testing Platform for G6PD Deficiency
FDA-cleared and CE-marked FINDER G6PD test provides glucose 6-phosphate dehydrogenase enzymatic activity in whole blood specimens using only a 50 microliter sample, enabling clinicians to quickly and accurately determine G6PDd status.
FINDER G6PD Test
Rapid time to result of ≅ 17 minutes
Simple workflow with no sample preparation
Lab-equivalent performance of <5% CV
Small footprint – the size of an A4 sheet of paper.
FINDER G6PD test is CE-marked and US FDA cleared.
*Latest Model of FINDER is not available for sale or use in any territory.
It has made a difference in the practice at our hospital. The ability to get a quantitative or semiquantitative value within 24 hours has made a difference in patient care, we really do appreciate this instrument.
Director, Hematology & Coagulation Laboratory
Baebies pricing structure and its technology platform were the primary drivers for pursuing the FINDER device.
